Evidence map›Paper›PMID 35140134›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

Mucosa-Associated Invariant T Cell Hypersensitivity to

Caroline Boulouis, Edwin Leeansyah, Srikanth Mairpady Shambat, Anna Norrby-Teglund, Johan K Sandberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Research progress on T-cell responses inFrontiers in microbiology · 2026
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. The Emerging Role of MAIT Cell Responses in Viral Infections.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  8. Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Caroline BoulouisCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0562-5395
Edwin LeeansyahCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0505-4967
Srikanth Mairpady ShambatCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Anna Norrby-TeglundCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-9372-1795
Johan K SandbergCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; johan.sandberg@ki.se.ORCID 0000-0002-6275-0750
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosa-associated invariant T (MAIT) cells recognize bacterial riboflavin metabolite Ags presented by MHC class Ib-related protein (MR1) and play important roles in immune control of microbes that synthesize riboflavin. This includes the pathobiont

Indexed as

CCR5 Receptor AntagonistsCell LineHumansImmune EvasionInterleukin-12 Subunit p35Interleukin-18Killer Cells, NaturalLeukocidinsLymphocyte ActivationMaravirocMucosal-Associated Invariant T CellsReceptors, CCR5Staphylococcal InfectionsStaphylococcus aureusTHP-1 CellsVirulence FactorsCCR5 protein, humanCCR5 Receptor AntagonistsIL12A protein, humanIL18 protein, humanInterleukin-12 Subunit p35Interleukin-18LeukocidinsMaravirocReceptors, CCR5Virulence Factors

Identifiers

PMID35140134
PMCPMC9012079
OpenAlexW4210907930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.